For three years, my partner has been venting the same dinner-table monologue:
"I can't find the anti-pTau again."
"Someone aliquoted the GFAP and didn't write it down."
"I think we have four tubes of the same antibody in four different freezers."
She's a neuroscientist. I'm a builder. Eventually, I did something about it.
I've yet to meet a lab that doesn't keep antibody inventory in a spreadsheet nobody trusts. The proper software is too expensive, too clunky, or both.
So I built AbTrove
i'll be sharing the build here — the wins, the failures, the weird things you learn talking to scientists for a living when you don't come from science.
if you're a founder, a builder, or a lab person who's tired of spreadsheets be sure to stick around.
For three years, my partner has been venting the same dinner-table monologue:
"I can't find the anti-pTau again."
"Someone aliquoted the GFAP and didn't write it down."
"I think we have four tubes of the same antibody in four different freezers."
She's a neuroscientist. I'm a builder. Eventually, I did something about it.
Her lab's been using it for a while. her colleagues kept asking for access, so we're opening it up.
If antibody chaos sounds familiar, try it free. https://t.co/oQPocHa8As
Building for scientists means accepting that for every clean structured field, there's a messy thought that needs to live next to it. "This lot was weird." "Don't use above 1:500." "Helen swears by this one." Notes fields are not optional.
Things scientists track with sticky notes that probably shouldn't be tracked with sticky notes: which dilution worked, which lot was the good one, where they put the tube
Building software for a domain you don't work in is humbling. Every demo with a researcher ends with me writing down new things I didn't know existed. (Today's word: "ARTAG". don’t ask me to explain it)
Check out my latest FREE research on where I think the $SPX will go based on an analysis of the Macro & Fundamentals... including price targets!
MacroVisor is a new project that @Mayhem4Markets and I founded to share views on the markets and the economy.
https://t.co/H0ylGAx02Y